Exelixis (EXEL) Cash & Equivalents (2010 - 2026)

Exelixis' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $226.2 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 23.07% year-over-year to $226.2 million; the TTM figure through Apr 2026 stood at $226.2 million (up 23.07% YoY), while the FY2026 annual figure was $482.5 million, up 121.96% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $226.2 million, down from $482.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $723.3 million in Q2 2022, with the low at $164.4 million in Q3 2025.
• The 5-year median for Cash & Equivalents is $376.3 million (2025), against an average of $385.8 million.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents plunged 57.27% in 2024, then soared 121.96% in 2026.
• Exelixis' Cash & Equivalents stood at $501.2 million in 2022, then slumped by 47.53% to $263.0 million in 2023, then decreased by 1.77% to $258.3 million in 2024, then jumped by 45.66% to $376.3 million in 2025, then slumped by 39.9% to $226.2 million in 2026.
• Business Quant data shows EXEL's Cash & Equivalents at $226.2 million in Q2 2026, $482.5 million in Q1 2026, and $376.3 million in Q4 2025.